Homozygous familiar hypercholesterolemia in China: Case series from the national lipid clinics and literature review
Conclusion In a conclusion, we found a relatively common recruitment of this type of patients in our hospital, which might have an important clinical implication for the identification and management of the patients with FH in China.
Source: IJC Metabolic and Endocrine - Category: Endocrinology Source Type: research
More News: Cholesterol | Crestor | Endocrinology | Genetics | Hospital Management | Rosuvastatin | Vytorin | Zetia